Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
| Status: | Completed |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Renal Impairment / Chronic Kidney Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Nephrology / Urology |
| Healthy: | No |
| Age Range: | 50 - Any |
| Updated: | 1/6/2019 |
| Start Date: | September 2011 |
| End Date: | December 2018 |
Systolic Pressure Intervention Trial (SPRINT)-Factors Affecting Factors Affecting Atherosclerosis Study (FAST)
Systolic Pressure Intervention Trial (SPRINT) is a large scale randomized trial of ~ 9250
adults aged 50 years or older with high cardiovascular risk sponsored by NIH. The study is
designed to recruit 45% of the study population with Chronic Kidney Disease (CKD). The trial
will test the effects of low systolic blood pressure (SBP) goal of < 120 mm Hg versus the
standard goal of < 140 mm Hg on the primary composite of cardiovascular events and death. One
of the pre-specified secondary outcome is the progression of kidney disease. In this
ancillary named SPRINT - Factors affecting Atherosclerosis STudy (FAST), the investigators
plan to take advantage of the unique opportunities afforded by the parent study to examine
issues that are of significant public health importance.
This is an observational study in SPRINT participants. This study will examine
mechanistically, the factors affecting the progression of atherosclerosis in CKD.
adults aged 50 years or older with high cardiovascular risk sponsored by NIH. The study is
designed to recruit 45% of the study population with Chronic Kidney Disease (CKD). The trial
will test the effects of low systolic blood pressure (SBP) goal of < 120 mm Hg versus the
standard goal of < 140 mm Hg on the primary composite of cardiovascular events and death. One
of the pre-specified secondary outcome is the progression of kidney disease. In this
ancillary named SPRINT - Factors affecting Atherosclerosis STudy (FAST), the investigators
plan to take advantage of the unique opportunities afforded by the parent study to examine
issues that are of significant public health importance.
This is an observational study in SPRINT participants. This study will examine
mechanistically, the factors affecting the progression of atherosclerosis in CKD.
Inclusion Criteria
- Systolic Pressure Intervention Trial (SPRINT) participants
Exclusion Criteria
- Contraindications to MRI (such as intracranial metal prostheses, weight > 300 pounds,
claustrophobia and certain types of hardware used in pacemakers, prostheses, etc.)
We found this trial at
12
sites
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
Click here to add this to my saved trials
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
Click here to add this to my saved trials
University of Utah Research is a major component in the life of the U benefiting...
Click here to add this to my saved trials
Univ of Washington Founded in 1861 by a private gift of 10 acres in what...
Click here to add this to my saved trials
Case Western Reserve Univ Continually ranked among America's best colleges, Case Western Reserve University has...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials